Concert Pharmaceuticals I...

NASDAQ: CNCE · Real-Time Price · USD
8.37
0.00 (0.00%)
At close: Mar 03, 2023, 10:00 PM

Concert Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2021
Period Ending Dec 31, 2021
Revenue
32.58M
Cost of Revenue
n/a
Gross Profit
32.58M
Operating Income
-77.51M
Interest Income
n/a
Pretax Income
-80.05M
Net Income
-82.59M
Selling & General & Admin
22.25M
Research & Development
87.56M
Other Expenses
283K
Operating Expenses
110.09M
Interest Expense
n/a
Selling & Marketing Expenses
n/a
Cost & Expenses
110.09M
Income Tax Expense
2.54M
Shares Outstanding (Basic)
34.41M
Shares Outstanding (Diluted)
34.41M
EPS (Basic)
-2.4
EPS (Diluted)
-2.4
EBITDA
-73.49M
EBIT
-77.51M
Depreciation & Amortization
4.02M